You have not verified your Email yet. Please verify your Email to create alerts
Verify Email
BAJAJHCARE
|
Bajaj Healthcare
|
Piramal Enterprises
|
Thyrocare Tech.
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Pharmaceutical Sector
|
|||
|
R&D as a % of Total Sales
|
0.59 % | n/a | n/a |
|
Financials
|
|||
|
5 yr Average ROE
|
18.48 % | 9.38 % | 23.13 % |
|
5yr average Equity Multiplier
|
2.14 | 2.82 | 1.36 |
|
5yr Average Asset Turnover Ratio
|
1.07 | 0.13 | 0.81 |
|
5yr Avg Net Profit Margin
|
8.14 % | 31.88 % | 21.31 % |
|
Price to Book
|
2.75 | 0.65 | 6.83 |
|
P/E
|
40.87 | 0.0 | 50.62 |
|
5yr Avg Cash Conversion Cycle
|
124.58 Days | -129.04 Days | 34.58 Days |
|
Inventory Days
|
53.75 Days | 28.97 Days | 16.27 Days |
|
Days Receivable
|
111.65 Days | 41.29 Days | 61.79 Days |
|
Days Payable
|
70.93 Days | 177.99 Days | 42.25 Days |
|
5yr Average Interest Coverage Ratio
|
7.43 | 1.49 | 114.35 |
|
5yr Avg ROCE
|
24.54 % | 10.09 % | 30.71 % |
|
5yr Avg Operating Profit Margin
|
16.5 % | 53.54 % | 37.85 % |
|
5 yr average Debt to Equity
|
0.75 | 1.56 | 0.0 |
|
5yr CAGR Net Profit
|
21.41 % | -17.79 % | -5.02 % |
|
5yr Average Return on Assets
|
8.79 % | 2.4 % | 17.28 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
67.73 % | 46.19 % | 71.11 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 100.0 % |
|
Change in Promoter Holding (3 Yrs)
|
0.47 % | 0.13 % | 4.97 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 5.29 % | 6.52 % |
|
Bajaj Healthcare
|
Piramal Enterprises
|
Thyrocare Tech.
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
-
|
Location Wise Break-Up
|
|
Operating Profit Break-Up
|
Operating Profit Break-Up
|
-
|
Operating Profit Break-Up
|
|
Asset Break-Up
|
Asset Break-Up
|
-
|
Asset Break-Up
|
